Predicting therapy response in live tumor cells isolated with the flexible micro spring array device

Cell Cycle

Volumn 12, Issue 13, 2013, Pages 2132-2143

  Gallant, Jean Nicolas ^a   Matthew, Elizabeth M ^a   Cheng, Hairong ^a,b   Harouaka, Ramdane ^c   Lamparella, Nicholas E ^a   Kunkel, Miriam ^a,d   Yang, Zhaohai ^d   Harvey, Harold A ^a   Cream, Leah V ^a   Kumar, Suresh M ^e   Robertson, Gavin P ^e   Zheng, Siyang ^c   Drabick, Joseph J ^a   Truica, Cristina I ^a   El Deiry, Wafik S ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

^b NORTHEAST NORMAL UNIVERSITY   (China)

^c The Pennsylvania State University   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Circulating tumor cells; Drug sensitivity testing; Microfluidic; Personalized medicine; Viable cell capture

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 8; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CELL ISOLATION; CHEMOSENSITIVITY; CIRCULATING TUMOR CELL; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; FLEXIBLE MICRO SPRING ARRAY; GENERAL DEVICE; HUMAN; HUMAN CELL; METASTASIS; METASTATIC COLORECTAL CANCER; MICROFLUIDICS; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL PARAMETERS; PROTEIN EXPRESSION; TREATMENT RESPONSE;

EID: 84879753901     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.25165     Document Type: Article

References (23)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90; PMID:21296855; http://dx.doi.org/ 10.3322/caac.20107
2. Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13:58-68; PMID:18167340; http://dx.doi.org/10.1016/j.ccr.2007.12.003
3. Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 2010; 16:790-9; PMID:20103678; http://dx.doi.org/10.1158/1078-0432.CCR-09-2446
4. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351:781-91; PMID:15317891; http://dx.doi.org/10.1056/NEJMoa040766
5. Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007; 13:7053-8; PMID:18056182; http://dx.doi.org/10.1158/1078-0432.CCR-07-1506
6. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26:3213-21; PMID:18591556; http://dx.doi.org/10.1200/JCO.2007. 15.8923
7. Tan SJ, Yobas L, Lee GY, Ong CN, Lim CT. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices 2009; 11:883-92; PMID:19387837; http://dx.doi.org/10.1007/s10544-009-9305-9
8. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007; 450:1235-9; PMID:18097410; http://dx.doi.org/10.1038/ nature06385
9. Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, et al. Isolation of circulating tumor cells using a microvortex-generating herringbonechip. Proc Natl Acad Sci USA 2010; 107:18392-7; PMID:20930119; http://dx.doi.org/10.1073/pnas.1012539107
10. Kuhn P, Bethel K. A fluid biopsy as investigating technology for the fluid phase of solid tumors. Phys Biol 2012; 9:010301; PMID:22306681; http://dx.doi.org/10.1088/1478-3975/9/1/010301
11. Fleischer RL, Price PB, Symes EM. Novel Filter for Biological Materials. Science 1964; 143:249-50; PMID:17753151; http://dx.doi.org/10.1126/science.143. 3603.249
12. Lin HK, Zheng S, Williams AJ, Balic M, Groshen S, Scher HI, et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 2010; 16:5011-8; PMID:20876796; http://dx.doi.org/10.1158/1078-0432.CCR-10-1105
13. Harouaka R, Zhou MD, Khan W, Yeh YT, Zheng SY. A flexible micro spring array (FMSA) device for the high throughput enrichment of viable CTCs. 103rd Annual Meeting of the American Association for Cancer Research; Chicago: AACR; 2012.
14. Harouaka R, Zhou MD, Zhang J, Khan W, Zheng SY. Development of a microfiltration system for the improved detection and viable capture of metastatic circulating tumor cells. 102nd Annual Meeting of the American Association for Cancer Research; Orlando: AACR; 2011.
15. Patel AS, Allen JE, Dicker DT, Peters KL, Sheehan JM, Glantz MJ, et al. Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget 2011; 2:752-60; PMID:21987585
16. Kirby BJ, Jodari M, Loftus MS, Gakhar G, Pratt ED, Chanel-Vos C, et al. Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. PLoS One 2012; 7:e35976; PMID:22558290; http://dx.doi.org/10.1371/journal.pone.0035976
17. Zheng S, Lin HK, Liu JQ, Balic M, Datar R, Cote RJ, et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 2007; 1162:154-61; PMID:17561026; http://dx.doi.org/10.1016/j.chroma.2007.05.064
18. Lin HK, Zheng S, Williams AJ, Balic M, Groshen S, Scher HI, et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 2010; 16:5011-8; PMID:20876796; http://dx.doi.org/10.1158/1078-0432.CCR-10-1105
19. Zheng S, Lin HK, Lu B, Williams A, Datar RH, Cote RJ, et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed Microdevices 2011; 13:203-13; PMID:20978853; http://dx.doi.org/10. 1007/s10544-010-9485-3
20. Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 2012; 487:510-3; PMID:22763454; http://dx.doi.org/10.1038/ nature11217
21. Oien KA. Pathologic evaluation of unknown primary cancer. Semin Oncol 2009; 36:8-37; PMID:19179185; http://dx.doi.org/10.1053/j.seminoncol.2008.10.009
22. Matthew EM, Zhou L, Yang Z, Lamparella N, Dicker DT, Yiu LL, et al. A Multiplexed Marker-based Algorithm for Diagnosis of Carcinoma of Unknown Primary Using CTCs. 103rd Annual Meeting of the American Association for Cancer Research; Chicago: AACR; 2012.
23. Navaraj A, Finnberg N, Dicker DT, Yang W, Matthew EM, El-Deiry WS. Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-Ras. Cancer Biol Ther 2009; 8:2417-44; PMID:20038817; http://dx.doi.org/10.4161/cbt.8.24.10850